Aggressive treatment of hyper or hypoosmolar conditions can trigger osmotic demyelination syndrome. We describe the case of a 53-year-old male who began using carbamazepine to treat bipolar affective disorder and was later diagnosed with carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion. The patient's mental state gradually improved once the hyponatremia was corrected using 3% normal saline and supportive therapy. The patient presented to the outpatient clinic with confusion and altered sensorium. Brain computed tomography showed diffuse cerebral atrophy and periventricular ischemia demyelination alterations, and magnetic resonance imaging showed an enhanced section in the brainstem that included the pons, suggesting osmotic demyelination alterations. Ventilatory support and supportive therapy were initiated, and hyponatremia was rectified. Although the patient did well with the treatment, his prognosis was still dismal, so he was sent home with instructions to follow up.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075004PMC
http://dx.doi.org/10.7759/cureus.35816DOI Listing

Publication Analysis

Top Keywords

carbamazepine-induced syndrome
8
syndrome inappropriate
8
inappropriate antidiuretic
8
antidiuretic hormone
8
osmotic demyelination
8
supportive therapy
8
demyelination alterations
8
central pontine
4
pontine myelinolysis
4
myelinolysis carbamazepine-induced
4

Similar Publications

Background: Stevens-Johnson Syndrome (SJS) is an infrequent yet severe mucocutaneous reaction that involves less than 10% of the Body Surface Area (BSA). It is predominantly induced by certain medications, including anticonvulsants (e.g.

View Article and Find Full Text PDF

Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

View Article and Find Full Text PDF

Importance: The HLA-B*15:02 allele has been associated with an increased risk of carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in specific Asian populations (including Han Chinese, Malaysian, Thai, and Vietnamese individuals). While HLA-B*15:02 genotype testing in Asian populations is recommended by several international prescribing guidelines, it is not subsidized by the Medicare Benefits Schedule in Australia.

Objective: To evaluate the cost-effectiveness of HLA-B*15:02 genotyping in Asian Australian patients with epilepsy.

View Article and Find Full Text PDF
Article Synopsis
  • This umbrella review investigates the link between the HLA-B*1502 gene and the development of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in patients taking certain antiepileptic medications.
  • A thorough search of Pubmed, Scopus, and EMBASE was conducted to gather relevant studies, which included systematic reviews, meta-analyses, and case-control studies assessing the HLA-B*1502 allele’s impact on various antiepileptics.
  • The review concludes that while the HLA-B*1502 allele poses a stronger risk for SJS/TEN with carbamazepine and oxcarbazepine, there is still a notable risk with lamot
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!